Sternocostoclavicular Hyperostosis

Subscribe to Selected New Research on Sternocostoclavicular Hyperostosis

8 relevant articles (3 outcomes, 0 trials/studies) found for this Disease

Description: A rare, benign rheumatologic disorder or syndrome characterized by hyperostosis and soft tissue ossification between the clavicles and the anterior part of the upper ribs. It is often associated with the dermatologic disorder palmoplantar pustulosis, particularly in Japan. Careful diagnosis is required to distinguish it from psoriatic arthritis, OSTEITIS DEFORMANS, and other diseases. Spondylitis of pustulosis palmaris et plantaris is one of the possible causes; also, evidence suggests one origin may be bone infection. Bone imaging is especially useful for diagnosis. It was originally described by Sonozaki in 1974.

Also Known As:

Hyperostosis, Sternocostoclavicular; Hyperostoses, Sternocostoclavicular; Sternocostoclavicular Hyperostoses

Relationship Network

Disease Context: Research Results

Musculoskeletal Diseases: 83

Rheumatic Diseases: 4787

Sternocostoclavicular Hyperostosis: 8

Bone Diseases: 2376

Hyperostosis: 176

Sternocostoclavicular Hyperostosis: 8

Skin and Connective Tissue Diseases

Connective Tissue Diseases: 1629

Rheumatic Diseases: 4787

Sternocostoclavicular Hyperostosis: 8

Related Diseases

1.	Pain (Aches)
2.	Osteoporosis
3.	Hyperostosis
4.	Focal Infection
5.	Psoriasis (Pustulosis Palmaris et Plantaris)
6 Diseases and 6 more articles analyzed in the Research Interface, order at left...

Experts

1.	Ringe, Johann D: 1 article (01/2006)
2.	Faber, Herbert: 1 article (01/2006)
3.	Farahmand, Parvis: 1 article (01/2006)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Sternocostoclavicular Hyperostosis:

1.	ibandronic acid (Boniva)FDA Link 01/01/2006 - "Rapid pain relief and remission of sternocostoclavicular hyperostosis after intravenous ibandronate therapy." 09/01/2007 - "Lower dose, less intense dosing regimens of ibandronate relieve bone pain in non-malignant conditions: i.v. ibandronate (2 mg every 3 months with or without an initial 4 mg injection) provides pain relief for patients with corticosteroid-induced osteoporosis, localised transient osteoporosis (bone marrow oedema) and sternocostoclavicular hyperostosis" Get all the results and reference details, order at left...
2.	Anti-Bacterial Agents (Antibiotics)IBA 08/01/1986 - "The similarities between age and sex distribution, and the responses to antibiotics of the patients with sternocostoclavicular hyperostosis and those with pustulosis suggest that these disorders have a common etiology, and that the pustulosis may represent "bacterid reaction", and the hyperostosis may also be a manifestation of a systemic reaction to a focal infection." 01/01/1986 - "The similarities between the age and sex distributions and the responses to antibiotics of the patients with sternocostoclavicular hyperostosis and those with pustulosis suggest that these disorders have a common etiology, and that the pustulosis may be a so-called bacterid reaction and the hyperostosis, a manifestation of a systemic reaction to a focal infection." Get all the results and reference details, order at left...
3.	HLA-B27 Antigen (HLA B27 Antigen)IBA 12/03/1988 - "Although patients with sternocostoclavicular hyperostosis usually lack the tissue type antigen HLA-B27, there are grounds for suspicion that the disease is related to the group of seronegative spondylo-arthritides." Get all the results and reference details, order at left...
4.	Technetium Tc 99m MedronateIBA 06/01/1986 - "Eleven patients with PPP who were suspected to have sternocostoclavicular hyperostosis were studied with Tc-99m MDP whole body bone imaging" Get all the results and reference details, order at left...
5.	Triad FDA Link 12/01/1998 - "It consists of the triad (a) palmo-plantar pustulosis (Ppp) or, alternatively, Königsbeck-Barber-type psoriasis, (b) sternocostoclavicular hyperostosis (SCCH), and (c) truncal-skeletal changes with syndesmophite-like, hyperostotic and/or parasyndesmophite-like ossifications of layers of the anterior vertebral ligament taken together in the sense of a desmophytal hyperostosis" Get all the results and reference details, order at left...
5 Drugs and Important Bio-Agents and 7 more articles analyzed in the Research Interface, order at left...

Therapies and Procedures

1.	Aftercare (After-Treatment) 03/01/1993 - "Both the local skin condition and the locomotory system improved after treatment, but sternocostoclavicular hyperostosis persisted" Get all the results and reference details, order at left...
1 Therapies and Procedures and 1 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>